NCT02872714 2025-08-14A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)Incyte CorporationPhase 2 Completed263 enrolled 20 charts
NCT04125693 2022-04-01Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its SafetyBayerPhase 2 Completed1 enrolled